ProPhase Labs, Inc.

PRPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $19.8M
Cost of Revenue $8.2M
Gross Profit $11.6M
Gross Margin 58.4%
Operating Expenses
Research & Development $1.3M
SG&A Expense $9.3M
Operating Income $-3.9M
Operating Margin -19.9%
Interest Expense
Pretax Income $-3.9M
Income Tax Expense $-84.0K
Net Income $-3.8M
Net Margin -19.4%
EPS (Basic) $0.00
EPS (Diluted) $0.00
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 3 of 3 Older →